Doma Perpetual Capital Management LLC Pacira Bio Sciences, Inc. Transaction History
Doma Perpetual Capital Management LLC
- $298 Billion
- Q3 2025
A detailed history of Doma Perpetual Capital Management LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Doma Perpetual Capital Management LLC holds 2,701,324 shares of PCRX stock, worth $64.2 Million. This represents 23.38% of its overall portfolio holdings.
Number of Shares
2,701,324
Previous 1,804,069
49.74%
Holding current value
$64.2 Million
Previous $44.8 Billion
55.28%
% of portfolio
23.38%
Previous 17.62%
Shares
8 transactions
Others Institutions Holding PCRX
# of Institutions
261Shares Held
48.9MCall Options Held
118KPut Options Held
63.7K-
Black Rock Inc. New York, NY8.01MShares$190 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.2MShares$124 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.16MShares$51.4 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.14MShares$50.8 Million0.08% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.94MShares$46.2 Million0.03% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.09B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...